Titan Pharmaceuticals Inc (TTNP)

[TRUISM]

EMail Response From The CDER

I emailed the CDER:

Dear Sir/Madam,



It appears that Probuphine has been reported to be effective:



Please keep this in mind when the new NDA is filed, as the epidemic takes another 44 lives daily.



Respectfully Stated,



xxxxxx xxxxx

Along with the Braeburn PR in it's entirety:


Braeburn reports positive topline results from Probuphine Phase 3 study for treatment of opioid addiction


Their response was:

Dear xxxxx xxxxxxx;



Thank you for writing the Division of Drug Information, in the FDA's Center for Drug Evaluation and Research (CDER). We are acknowledging the receipt of the comments in your email.



You may also periodically check for drug approval notifications at the following link: www.fda.gov/Drugs/NewsEvents/ucm130961.htm



We hope the information provided to you is helpful. If you have questions, please do not hesitate to contact us again.



Best Regards,



AA,

Drug Information Specialist

Division of Drug Information | Center for Drug Evaluation and Research

Food and Drug Administration

Blessings to All

TRUTH